[Nang Kuang] Announcement regarding the approval of lifting non-compete restrictions for directors at the 2026 Annual General Meeting
NQ Score
49/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.
AI Analysis
Frequently Asked Questions
- Q: What is a non-compete waiver?
- A: It allows directors to engage in business activities that might otherwise conflict with the company.